Literature DB >> 467339

Independent inhibition of prolactin secretion by dopamine and gamma-aminobutyric acid in vitro.

A Enjalbert, M Ruberg, S Arancibia, L Fiore, M Priam, C Kordon.   

Abstract

gamma-Aminobutyric acid (GABA) inhibits PRL release from incubated hemipituitaries in a dose-dependent manner. The maximum inhibition obtained with GABA is less than that obtained with dopamine. Its affinity is 100 times lower. The effect is blocked by picrotoxin but not by a dopamine inhibitor; alpha-flupentixol but not picrotoxin antagonizes dopamine inhibition. This indicates that dopamine and GABA inhibit PRL release through independent receptors. The hypothalamic extract contains sufficient GABA to inhibit PRL release in our in vitro conditions. Picrotoxin, however, does not significantly inhibit the nondopaminergic PRL-inhibiting activity of mediobasal hypothalamic extracts. Another nondopaminergic PRL-inhibiting factor, therefore, seems to be present in the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 467339     DOI: 10.1210/endo-105-3-823

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  GABA-ergic control of prolactin release in rainbow trout (Oncorhynchus mykiss) pituitaries in vitro.

Authors:  P Prunet; J F Gonnard; G Paboeuf
Journal:  Fish Physiol Biochem       Date:  1993-07       Impact factor: 2.794

Review 2.  Ontogenic studies of the neural control of adenohypophyseal hormones in the rat. II. Prolactin.

Authors:  D Becú-Villalobos; I M Lacau-Mengido; G S Díaz-Torga; C Libertun
Journal:  Cell Mol Neurobiol       Date:  1992-02       Impact factor: 5.046

3.  Molecular, pharmacological and functional properties of GABA(A) receptors in anterior pituitary cells.

Authors:  Hana W Zemkova; Ivana Bjelobaba; Melanija Tomic; Hana Zemkova; Stanko S Stojilkovic
Journal:  J Physiol       Date:  2008-05-01       Impact factor: 5.182

4.  Systematic presence of GABA-immunoreactivity in the tubero-infundibular and tubero-hypophyseal dopaminergic axonal systems: an ultrastructural immunogold study on several mammals.

Authors:  S Schimchowitsch; P Vuillez; M L Tappaz; M J Klein; M E Stoeckel
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

5.  Estriol affects prolactin and LH secretion in rats.

Authors:  M C Diaz; A Seilicovich; B H Duvilanski; N Siseles; M Lasaga; L Debeljuk
Journal:  J Endocrinol Invest       Date:  1989-01       Impact factor: 4.256

6.  Central GABAergic innervation of neurointermediate pituitary lobe: biochemical and immunocytochemical study in the rat.

Authors:  W H Oertel; E Mugnaini; M L Tappaz; V K Weise; A L Dahl; D E Schmechel; I J Kopin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.

Authors:  G M Besser; G Delitala; A Grossman; W A Stubbs; T Yeo
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  Comparison between the interaction of steroids with [35S]TBPS binding to cerebral cortical and to pituitary membranes: correlation with inhibition of prolactin release.

Authors:  M Vincens; C Shu; M Fortin; D Philibert; M Gaillard-Moguilewsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

9.  Regulation of prolactin secretion during suckling: involvement of the hypothalamo-pituitary GABAergic system.

Authors:  G Racagni; J A Apud; D Cocchi; V Locatelli; E Iuliano; F Casanueva; E E Müller
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

Review 10.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.